The influence of socioeconomic status on individual attitudes and experience with clinical trials

被引:3
|
作者
Kim, Jennifer Y. [1 ]
Florez, Maria [1 ]
Botto, Emily [1 ]
Belgrave, Xoli [2 ]
Grace, Clare [2 ]
Getz, Ken [1 ]
机构
[1] Tufts Univ, Tufts Ctr Study Drug Dev, Sch Med, Boston, MA 02155 USA
[2] Parexel, Durham, NC USA
来源
COMMUNICATIONS MEDICINE | 2024年 / 4卷 / 01期
关键词
WOMENS PERCEPTIONS; PROSTATE-CANCER; PARTICIPATION; BARRIERS;
D O I
10.1038/s43856-024-00586-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundCharacterizing perceptions of clinical trials among the socioeconomically disadvantaged is necessary for understanding how social determinants of health such as socioeconomic disparities in education and income can affect people's awareness of and exposure to clinical trialsMethodsA survey was distributed in spring 2023 among a survey taking sample stratified by demographic variables to reflect the U.S. population. The survey assessed the socioeconomic status of the respondent and related covariates, as well as outcome measures including interest in joining a clinical trial, concerns relating to participation, and whether the respondent had previously been asked to participate. Multiple and logistic regression were used to assess the relationship between predictor and outcome variablesResultsHere we show the results of outcome measures regressed on main predictors related to socioeconomic status and related demographic predictors. Education, employment status, insurance coverage, and English proficiency were significant predictors of interest in clinical trial participation. Education and the presence of a healthcare professional or former clinical trial participant in the respondent's personal network were significant predictors of whether the respondent had previously been asked to participate in a clinical trialConclusionsThe results of the analysis reveal how socioeconomically vulnerable groups, including those from low income and low education groups, are being excluded in clinical research. Analyses also uncovered the impact of clinical trial social influence-the presence of having a family or friend in one's social network who participated in a clinical trial-on willingness to participate and exposure to clinical trials. Participation in clinical trials has remained largely inaccessible to historically underrepresented communities, which includes groups that are low income and low education. Here, we examine socioeconomic and demographic factors that can influence individuals' willingness to participate in clinical trials and their experience being asked to participate in clinical trials. Using several types of analysis, we show that those who are low income and less educated are less willing to participate in clinical trials and are less likely to be asked to participate in clinical trials when compared to those with higher income and more education. This highlights the need for improved outreach among healthcare providers and clinical research staff to include these communities and provide individuals with the knowledge, awareness, and opportunity to participate in clinical trials. Kim et. al explore the impact of socioeconomic vulnerability on clinical trial participation. Findings highlight barriers to trial entry including participant concerns and implications of exclusion of specific groups.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Effect of Patient Socioeconomic Status on Access to Early-Phase Cancer Trials
    Noor, Aisyah Mohd
    Sarker, Debashis
    Vizor, Suzanne
    McLennan, Blair
    Hunter, Sarah
    Suder, Aneta
    Moller, Henrik
    Spicer, James F.
    Papa, Sophie
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (02) : 224 - 230
  • [22] Knowledge of and attitudes toward clinical trials in Saudi Arabia: a cross-sectional study
    Al-Rawashdeh, Nedal
    Damsees, Rana
    Al-Jeraisy, Majed
    Al Qasim, Eman
    Deeb, Ahmad M.
    BMJ OPEN, 2019, 9 (10):
  • [23] Influence of race and socioeconomic status on engagement in pediatric primary care
    Cox, Elizabeth D.
    Nackers, Kirstin A.
    Young, Henry N.
    Moreno, Megan A.
    Levy, Joseph F.
    Mangione-Smith, Rita M.
    PATIENT EDUCATION AND COUNSELING, 2012, 87 (03) : 319 - 326
  • [24] Barriers and motivations for participation in preventive vaccine clinical trials: Experience of 5 clinical research sites
    Detoc, M.
    Launay, O.
    Duale, C.
    Mutter, C.
    Le Huec, J-C
    Lenzi, N.
    Lucht, F.
    Gagneux-Brunon, A.
    Botelho-Nevers, E.
    VACCINE, 2019, 37 (44) : 6633 - 6639
  • [25] Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland
    Kearns, Cathriona
    Feighery, Ronan
    Mc Caffrey, John
    Higgins, Michaela
    Smith, Martina
    Murphy, Verena
    O'Reilly, Seamus
    Horgan, Anne M.
    Walshe, Janice
    McDermott, Ray
    Morris, Patrick G.
    Keane, Maccon
    Martin, Michael
    Murphy, Conleth
    Duffy, Karen
    Mihai, Alina
    Armstrong, John
    O'Donnell, Dearbhaile M.
    Gallagher, William M.
    Kelly, Ciara M.
    Kelly, Catherine M.
    CANCERS, 2020, 12 (07) : 1 - 26
  • [26] Sunscreen use and affordability attitudes based on ethnicity, socioeconomic status, and Fitzpatrick skin type
    Ullman, Lori E.
    Nasir-Moin, Mehr
    Hoffman, Victoria
    Ghadersohi, Sarah
    Swartzman, Isaac
    de Weever, Malaika
    Augustin, Michael
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (06)
  • [27] Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines
    Symonds, R. P.
    Lord, K.
    Mitchell, A. J.
    Raghavan, D.
    BRITISH JOURNAL OF CANCER, 2012, 107 (07) : 1017 - 1021
  • [28] The attitudes of oncology physicians and nurses toward phase I, II, and III cancer clinical trials
    Zhang, Jie
    Zhang, Hong
    Yu, Chunhua
    Li, Junying
    Jiang, Yu
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (05) : 649 - 653
  • [29] Organisational factors influencing early clinical trials enrollment: Gustave Roussy experience
    Besle, Sylvain
    Schultz, Emilien
    Hollebecque, Antoine
    Varga, Andreea
    Baldini, Capucine
    Martin, Patricia
    Postel-Vinay, Sophie
    Bahleda, Rastislav
    Gazzah, Anas
    Michot, Jean-Marie
    Marabelle, Aurelien
    Angevin, Eric
    Armand, Jean-Pierre
    Ribrag, Vincent
    Soria, Jean-Charles
    Massard, Christophe
    EUROPEAN JOURNAL OF CANCER, 2018, 98 : 17 - 22
  • [30] CBER's Experience With Adaptive Design Clinical Trials
    Lin, Min
    Lee, Shiowjen
    Zhen, Boguang
    Scott, John
    Horne, Amelia
    Solomon, Ghideon
    Russek-Cohen, Estelle
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (02) : 195 - 203